Pre-market · Oct 6, 7:20 am ET · After hours $16.32 +0.28%
Open$16.02
Prev close$15.90
Day range$15.53 – $16.65
Volume22.32M
Market cap$1.85B
P/E (TTM)–
Dividend yield4.92%
OLN Stock News
Headlines matching Olin or the OLN ticker, most recent first.
Goldman Sachs Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $18Market news · 30 Sep 2026
Citi Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $17Market news · 30 Sep 2026
Mizuho Securities Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $21Market news · 23 Sep 2026
Citi Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $19Market news · 15 Sep 2026
J.P. Morgan Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $19Market news · 5 Aug 2026
Goldman Sachs Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20Market news · 4 Aug 2026
Wells Fargo Downgrades Olin(OLN.US) to Hold Rating, Cuts Target Price to $20Market news · 4 Aug 2026
RBC Capital Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20Market news · 3 Aug 2026
BofA Securities Downgrades Olin(OLN.US) to Sell RatingMarket news · 3 Aug 2026
Truist Financial Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20Market news · 3 Aug 2026
UBS Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $21Market news · 3 Aug 2026
Deutsche Bank Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20Market news · 25 Aug 2026
Chengdu Olymvax Biopharmaceuticals Inc: Annual Report Summary 2025 of Chengdu Olin Bio-Tech Co., Ltd.SZSI · 31 Mar 2026
Chengdu Olymvax Biopharmaceuticals Inc: Special Report on the Deposit, Management, and Actual Use of Raised Funds by Chengdu Olin Bio-Tech Co., Ltd. for the 2025 Fiscal YearSZSI · 31 Mar 2026
UBS Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $18Market news · 5 Oct 2026
Discussion
No comments yet — be the first to weigh in on OLN.
No comments yet — be the first to weigh in on OLN.